Terns Pharmaceuticals, Inc. 10-K Cybersecurity GRC - 2024-03-14

Page last updated on July 16, 2024

Terns Pharmaceuticals, Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-03-14 16:15:50 EDT.

Filings

10-K filed on 2024-03-14

Terns Pharmaceuticals, Inc. filed a 10-K at 2024-03-14 16:15:50 EDT
Accession Number: 0000950170-24-031497

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

Item 1C. Cybersecurity. The audit committee of our board of directors is responsible for the general oversight around cybersecurity-related matters, while our management is responsible for the day-to-day operations around the assessment and management of any cybersecurity risks we might face. Our board of directors and the audit committee, in consultation with management, established and maintained robust procedures and internal controls around cybersecurity. These mechanisms are designed to help protect our information assets and operations from internal and external cyber threats, protect employee and clinical trial information from unauthorized access or attack, as well as secure our networks and systems. At each regularly scheduled audit committee meeting, our chief financial officer provides an update on our cybersecurity position, and where necessary, the audit committee then provides an update to the board of directors. Our incident response process also contemplates that the executive team will notify the audit committee of a material cybersecurity incident. We engage an experienced consultant to oversee the day-to-day functions of cybersecurity management, including proactive reviews of activity logs, regular vulnerability scans, and, where applicable, effective incident response. Our expert consultant has over 30 years of experience in the cybersecurity space, and reports to the chief financial officer . We also engage a highly qualified third-party cybersecurity assessor to conduct annual threat assessments and penetration tests. To date, we have not encountered cybersecurity incidents that have materially impacted our operations or financial standing. 97


Company Information

NameTerns Pharmaceuticals, Inc.
CIK0001831363
SIC DescriptionPharmaceutical Preparations
TickerTERN - Nasdaq
Website
CategoryNon-accelerated filer
Smaller reporting company
Emerging growth company
Fiscal Year EndDecember 30